American Healthcare REIT (AHR) EBITDA (2016 - 2026)

American Healthcare REIT has reported EBITDA for 11 years, with the latest figure at $23.9 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA rose 460.46% year-over-year to $23.9 million; the trailing twelve-month figure through Mar 2026 stood at $100.8 million (up 362.56% YoY), and the FY2025 full-year result was $70.2 million, up 296.75% from the prior year.
• EBITDA for Q1 2026 stood at $23.9 million, up from $9.9 million in the prior quarter.
• The five-year high for EBITDA was $56.5 million in Q3 2025, with the low at -$39.2 million in Q4 2022.
• Historically, EBITDA has averaged -$5.0 million across 5 years, with a median of -$6.2 million in 2023.
• Annual changes were most pronounced in 2023 — EBITDA sank 2419.98% — and 2025, when it jumped 1578.37%.
• American Healthcare REIT's EBITDA stood at -$39.2 million in 2022, then jumped by 35.31% to -$25.3 million in 2023, then slipped by 18.06% to -$29.9 million in 2024, then jumped by 133.22% to $9.9 million in 2025, then soared by 140.4% to $23.9 million in 2026.
• The last three EBITDA figures came in at $23.9 million (Q1 2026), $9.9 million (Q4 2025), and $56.5 million (Q3 2025), per Business Quant data.